Cargando…

Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients

BACKGROUND: Hypermetabolism and hyposomatotropism related to severe burns lead to impaired wound healing. Growth hormone (GH) boosts wound healing notably following stimulation of the production of insulin-like growth factor-1 (IGF1), a mitogen factor for keratinocytes. Gamma-hydroxybutyrate (GHB) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousseau, Anne-Françoise, Bargues, Laurent, Bever, Hervé Le, Vest, Philippe, Cavalier, Etienne, Ledoux, Didier, Piérard, Gérald E., Damas, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093961/
https://www.ncbi.nlm.nih.gov/pubmed/25024938
http://dx.doi.org/10.4103/2229-5151.134150
_version_ 1782325782830383104
author Rousseau, Anne-Françoise
Bargues, Laurent
Bever, Hervé Le
Vest, Philippe
Cavalier, Etienne
Ledoux, Didier
Piérard, Gérald E.
Damas, Pierre
author_facet Rousseau, Anne-Françoise
Bargues, Laurent
Bever, Hervé Le
Vest, Philippe
Cavalier, Etienne
Ledoux, Didier
Piérard, Gérald E.
Damas, Pierre
author_sort Rousseau, Anne-Françoise
collection PubMed
description BACKGROUND: Hypermetabolism and hyposomatotropism related to severe burns lead to impaired wound healing. Growth hormone (GH) boosts wound healing notably following stimulation of the production of insulin-like growth factor-1 (IGF1), a mitogen factor for keratinocytes. Gamma-hydroxybutyrate (GHB) stimulates endogenous GH secretion. AIM: To assess effects of GHB sedation on keratinocytes proliferation (based on immunohistochemical techniques). DESIGN: Monocentric, prospective, controlled trial. MATERIALS AND METHODS: Patients (aging 18-65 years, burn surface area >30%, expected to be sedated for at least one month) were alternately allocated, at the 5(th) day following injury, in three groups according to the intravenous GHB dose administered for 21 days: Evening bolus of 50 mg/kg (Group B), continuous infusion at the rate of 10 mg/kg/h (Group C), or absence of GHB (Group P). They all received local standard cares. Immunohistochemistry (Ki67/MIB-1, Ulex europaeus agglutinin-1 and Mac 387 antibodies) was performed at D21 on adjacent unburned skin sample for assessing any keratinocyte activation. Serum IGF1 levels were measured at initiation and completion of the protocol. STATISTICAL ANALYSIS: Categorical variables were compared with Chi-square test. Comparisons of medians were made using Kruskal-Wallis test. Post hoc analyses were performed using Mann-Whitney test with Bonferroni correction for multiple comparisons. A P < 0.05 was considered to be statistically significant. RESULTS: A total of 14 patients completed the study (Group B: n = 5, Group C: n = 5, Group P: n = 4). Continuous administration of GHB was associated with a significant higher Ki67 immunolabeling at D21 (P = 0.049) and with a significant higher increase in the IGF1 concentrations at D21 (P = 0.024). No adverse effects were disclosed. CONCLUSIONS: Our preliminary data support a positive effect of GHB on keratinocyte proliferation and are encouraging enough to warrant large prospective studies.
format Online
Article
Text
id pubmed-4093961
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40939612014-07-14 Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients Rousseau, Anne-Françoise Bargues, Laurent Bever, Hervé Le Vest, Philippe Cavalier, Etienne Ledoux, Didier Piérard, Gérald E. Damas, Pierre Int J Crit Illn Inj Sci Original Article BACKGROUND: Hypermetabolism and hyposomatotropism related to severe burns lead to impaired wound healing. Growth hormone (GH) boosts wound healing notably following stimulation of the production of insulin-like growth factor-1 (IGF1), a mitogen factor for keratinocytes. Gamma-hydroxybutyrate (GHB) stimulates endogenous GH secretion. AIM: To assess effects of GHB sedation on keratinocytes proliferation (based on immunohistochemical techniques). DESIGN: Monocentric, prospective, controlled trial. MATERIALS AND METHODS: Patients (aging 18-65 years, burn surface area >30%, expected to be sedated for at least one month) were alternately allocated, at the 5(th) day following injury, in three groups according to the intravenous GHB dose administered for 21 days: Evening bolus of 50 mg/kg (Group B), continuous infusion at the rate of 10 mg/kg/h (Group C), or absence of GHB (Group P). They all received local standard cares. Immunohistochemistry (Ki67/MIB-1, Ulex europaeus agglutinin-1 and Mac 387 antibodies) was performed at D21 on adjacent unburned skin sample for assessing any keratinocyte activation. Serum IGF1 levels were measured at initiation and completion of the protocol. STATISTICAL ANALYSIS: Categorical variables were compared with Chi-square test. Comparisons of medians were made using Kruskal-Wallis test. Post hoc analyses were performed using Mann-Whitney test with Bonferroni correction for multiple comparisons. A P < 0.05 was considered to be statistically significant. RESULTS: A total of 14 patients completed the study (Group B: n = 5, Group C: n = 5, Group P: n = 4). Continuous administration of GHB was associated with a significant higher Ki67 immunolabeling at D21 (P = 0.049) and with a significant higher increase in the IGF1 concentrations at D21 (P = 0.024). No adverse effects were disclosed. CONCLUSIONS: Our preliminary data support a positive effect of GHB on keratinocyte proliferation and are encouraging enough to warrant large prospective studies. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4093961/ /pubmed/25024938 http://dx.doi.org/10.4103/2229-5151.134150 Text en Copyright: © International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rousseau, Anne-Françoise
Bargues, Laurent
Bever, Hervé Le
Vest, Philippe
Cavalier, Etienne
Ledoux, Didier
Piérard, Gérald E.
Damas, Pierre
Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients
title Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients
title_full Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients
title_fullStr Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients
title_full_unstemmed Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients
title_short Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients
title_sort effect of gamma-hydroxybutyrate on keratinocytes proliferation: a preliminary prospective controlled study in severe burn patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093961/
https://www.ncbi.nlm.nih.gov/pubmed/25024938
http://dx.doi.org/10.4103/2229-5151.134150
work_keys_str_mv AT rousseauannefrancoise effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients
AT bargueslaurent effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients
AT beverhervele effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients
AT vestphilippe effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients
AT cavalieretienne effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients
AT ledouxdidier effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients
AT pierardgeralde effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients
AT damaspierre effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients